SCHEMBL9960249

SCHEMBL9960249

CC1CC(C)C(=O)C(C)(C)C1=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9959271 0.79 NOS3 (0.31)
SCHEMBL10589121 0.73
SCHEMBL15660011 0.72 CRBN (0.35) CRBN
SCHEMBL2986423 0.71
SCHEMBL3862479 0.70
SCHEMBL13811069 0.69 POLB (0.31)
SCHEMBL1238109 0.69 CA1 (0.34)
SCHEMBL5713367 0.69 CA1 (0.34)
SCHEMBL9963671 0.69 CYP19A1 (0.33)
SCHEMBL873396 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2467364-A2 NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION Otsuka Pharmaceutical Co., Ltd. (JP) 2012-06-27 EP disclosed